| Domain | Rank | Visitors | Earning per month | Valuation |
| fiercebiotech.com | 68200 | 19,328 | 2,337$ | 70110$ |
| biospace.com | 52236 | 8,927 | 2,491$ | 74730$ |
| pharmaceutical-technology.com | 180506 | 14,910 | 1,664$ | 49920$ |
| endpts.com | 115404 | 9,795 | 1,640$ | 49200$ |
| biopharmadive.com | 224424 | 4,665 | 607$ | 18210$ |
| massdevice.com | 251870 | 2,755 | 359$ | 10770$ |
| genengnews.com | 139166 | 10,122 | 1,130$ | 33900$ |
| databridgemarketresearch.com | 51049 | 2,008 | 1,102$ | 33060$ |
| Moz Backlinks Count | 2204 |
| Moz Page Rank | 4 |
| Domain Authority (DA) | 67.0 |
| Page Authority (PA) | 47.0 |
| Country | Rank | Pct |
|---|
| Country Name | United States |
| Country Rank | 21079
7070
|
| Daily unique visits | 22,671 |
| Daily Page Views | 31,739 |
| Income Per Day | 2,952 USD |
| Fiercepharma.com valuation | 88560 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | Appeals court backs short sentences in GSK trade secrets case |
| 2 | Novo Nordisk's Wegovy woes were an unexpected boon for Saxenda |
| 3 | The Connected TV Opportunity for Pharma Marketers |
| 4 | Unused inventory, production capacity add up for Moderna in Q2 |
| 5 | Regeneron expects approval delay of Libtayo plus chemo in NSCLC |
| 6 | Merck's Keytruda extends losing streak with pair of trial flops |
| 7 | Hanmi relaunches liver drug after boosting bioavailability |
| 8 | Biora, with spin on Xeljanz nearing clinic, posts delivery data |
| 9 | Chiesi enlists support for nose-to-brain biologic delivery push |
| 10 | What marketers can do to get ahead of social media messaging |
| Social | Count |
| Facebook Likes | 183 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |